Literature DB >> 21512096

18F-FDG PET/CT of cervical carcinoma.

Chirag N Patel1, Sarfraz A Nazir, Zubair Khan, Fergus V Gleeson, Kevin M Bradley.   

Abstract

OBJECTIVE: This article outlines the role of FDG PET/CT in patients with cervical carcinoma for evaluating tumor extent, assessing treatment response, and detecting disease recurrence.
CONCLUSION: There is increasing evidence that FDG PET/CT has a role in the primary evaluation of cervical carcinoma-in particular, for evaluating lymph node status and distant metastatic disease. PET/CT is also helpful to determine prognosis, assess treatment response, and evaluate disease recurrence.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21512096     DOI: 10.2214/AJR.10.5084

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  9 in total

Review 1.  Positron Emission Tomography (PET) in Oncology.

Authors:  Andrea Gallamini; Colette Zwarthoed; Anna Borra
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

Review 2.  Radiotherapy for cervical cancer: Chilean consensus of the Society of Radiation Oncology.

Authors:  Felipe Carvajal; Claudia Carvajal; Tomás Merino; Verónica López; Javier Retamales; Evelyn San Martín; Freddy Alarcón; Mónica Cuevas; Francisca Barahona; Ignacio Véliz; Juvenal A Ríos; Sergio Becerra
Journal:  Rep Pract Oncol Radiother       Date:  2021-04-14

3.  Simultaneous PET/MRI: Impact on cancer management-A comprehensive review of cases.

Authors:  Amarnath Jena; Sangeeta Taneja; Abhishek Jha
Journal:  Indian J Radiol Imaging       Date:  2014-04

4.  The Role of (18) F-FDG PET/CT in Assessing Therapy Response in Cervix Cancer after Concurrent Chemoradiation Therapy.

Authors:  Jiyoun Choi; Hyun Jeong Kim; Yong Hyu Jeong; Jae-Hoon Lee; Arthur Cho; Mijin Yun; Jong Doo Lee; Yong Bae Kim; Young Tae Kim; Won Jun Kang
Journal:  Nucl Med Mol Imaging       Date:  2013-11-15

5.  Diagnostic efficiency of whole-body 18F-FDG PET/MRI, MRI alone, and SUV and ADC values in staging of primary uterine cervical cancer.

Authors:  Aida Steiner; Sara Narva; Irina Rinta-Kiikka; Sakari Hietanen; Johanna Hynninen; Johanna Virtanen
Journal:  Cancer Imaging       Date:  2021-01-22       Impact factor: 3.909

Review 6.  A Review of Nuclear Medicine Approaches in the Diagnosis and the Treatment of Gynecological Malignancies.

Authors:  Nasim Vahidfar; Saeed Farzanefar; Hojjat Ahmadzadehfar; Eóin N Molloy; Elisabeth Eppard
Journal:  Cancers (Basel)       Date:  2022-03-31       Impact factor: 6.639

Review 7.  Implications of the revised cervical cancer FIGO staging system.

Authors:  Neerja Bhatla; Seema Singhal; Ekta Dhamija; Sandeep Mathur; Jayashree Natarajan; Amita Maheshwari
Journal:  Indian J Med Res       Date:  2021-08       Impact factor: 5.274

8.  Fluorodeoxyglucose positron emission tomography-computed tomography in evaluation of pelvic and para-aortic nodal involvement in early stage and operable cervical cancer: Comparison with surgicopathological findings.

Authors:  Vandana Bansal; Kaizad Damania; Anshu Rajnish Sharma
Journal:  Indian J Nucl Med       Date:  2011-10

9.  Diagnostic value and clinical significance of MRI and CT in detecting lymph node metastasis of early cervical cancer.

Authors:  Lan Luo; Qian Luo; Liang Tang
Journal:  Oncol Lett       Date:  2019-12-04       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.